Drug Shortage Report for MED-DORZOLAMIDE-TIMOLOL

Last updated on 2021-04-23 History
Report ID 100744
Drug Identification Number 02437686
Brand name MED-DORZOLAMIDE-TIMOLOL
Common or Proper name Med- Dorzolamide Timolol
Company Name GENERIC MEDICAL PARTNERS INC
Market Status MARKETED
Active Ingredient(s) TIMOLOL DORZOLAMIDE
Strength(s) 5MG 20MG
Dosage form(s) SOLUTION
Route of administration OPHTHALMIC
Packaging size 1 bottle
ATC code S01ED
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Demand increase for the drug.
Anticipated start date 2019-12-10
Actual start date 2019-12-10
Estimated end date
Actual end date 2020-02-17
Shortage status Resolved
Updated date 2021-04-23
Company comments Med-Dorzolamide Timolol is not in shortage. The Shortage Report was not closed. This report is to state that the shortage ended a year ago. GMP has large amounts of stock.
Health Canada comments
Tier 3 Status No
Contact Address 1500 DON MILLS ROAD, SUITE 711
TORONTO, ONTARIO
CANADA M3B 3K4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2021-04-23 French Compare
v6 2021-04-23 English Compare
v5 2019-12-11 English Compare
v4 2019-12-10 French Compare
v3 2019-12-10 French Compare
v2 2019-12-10 French Compare
v1 2019-12-10 English Compare

Showing 1 to 7 of 7